Singapore markets closed

CytomX Therapeutics Inc (6C1.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.7560+0.0560 (+3.29%)
As of 07:08PM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
16,533
-569
-99,317
-115,870
-64,820
Depreciation & amortisation
2,047
2,175
2,443
2,706
2,573
Stock-based compensation
8,056
8,558
13,125
13,167
14,786
Change in working capital
-114,129
-62,509
-30,654
-22,439
50,069
Accounts receivable
-12,087
32,554
-35,196
8
-785
Accounts payable
-227
-1,426
68
-139
-857
Other working capital
-92,336
-56,875
-112,528
-120,640
2,950
Other non-cash items
3,814
3,729
3,413
3,133
2,887
Net cash provided by operating activities
-91,429
-56,035
-110,788
-119,031
5,259
Cash flows from investing activities
Investments in property, plant and equipment
-907
-840
-1,740
-1,609
-2,309
Purchases of investments
-278,240
-424,834
0
-99,898
-199,108
Sales/maturities of investments
320,000
275,000
100,000
123,996
182,699
Net cash used for investing activities
40,853
-150,674
98,260
22,489
-18,718
Cash flows from financing activities
Common stock issued
-
-
0
107,712
11,288
Net cash used provided by (used for) financing activities
30,404
30,230
648
110,213
16,893
Net change in cash
-20,172
-176,479
-11,880
13,671
3,434
Cash at beginning of period
57,274
194,567
206,447
192,776
189,342
Cash at end of period
37,102
18,088
194,567
206,447
192,776
Free cash flow
Operating cash flow
-91,429
-56,035
-110,788
-119,031
5,259
Capital expenditure
-907
-840
-1,740
-1,609
-2,309
Free cash flow
-92,336
-56,875
-112,528
-120,640
2,950